Lemaitre Vascular (LMAT) Other Non Operating Income (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Other Non Operating Income came in at -$127000.0 in Q1 2026, down 6450.0% year-on-year from $2000.0 in Q1 2025, and up 78.51% on a QoQ basis from -$591000.0 in Q4 2025.
Lemaitre Vascular (LMAT) Other Non Operating Income (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Other Non Operating Income data on file, last reported at -$127000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 6450.0% year-over-year to -$127000.0 in Q1 2026; TTM through Mar 2026 was -$777000.0, a 296.21% decrease from a year earlier, with the FY2025 full-year figure at -$648000.0, down 305.06% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$127000.0, up from -$591000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for LMAT reached as high as $406000.0 in Q4 2023 and fell as low as -$591000.0 in Q4 2025.
- Historically, Other Non Operating Income has averaged -$47470.6 across 5 years, with a median of -$40000.0 in 2022.
- Across the five-year window, Other Non Operating Income soared 3590.91% in 2022 and slumped 6450.0% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at $384000.0 in 2022, then rose by 5.73% to $406000.0 in 2023, then slumped by 50.0% to $203000.0 in 2024, then tumbled by 391.13% to -$591000.0 in 2025, then surged by 78.51% to -$127000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$127000.0 in Q1 2026, -$591000.0 in Q4 2025, and -$306000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127,000.00 |
| Dec 31, 2025 | -591,000.00 |
| Sep 30, 2025 | -306,000.00 |
| Jun 30, 2025 | 247,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Sep 30, 2024 | 202,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -78,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | -189,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | -425,000.00 |
| Dec 31, 2022 | 384,000.00 |
| Sep 30, 2022 | -266,000.00 |
| Jun 30, 2022 | -403,000.00 |
| Mar 31, 2022 | -40,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Sep 30, 2021 | -72,000.00 |
| Jun 30, 2021 | -157,000.00 |